Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Veterinary and Human Toxicology|October 4, 2002
Lymphadenopathy secondary to lamotrigine (Lamictal)Jeanna M Marraffa, Roy GuharoyClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2020
US Food and Drug Administration (FDA) Emergency Use Authorization: Glass Half Full or Glass Half Empty?Roy Guharoy, Edward P KrenzelokClinical Toxicology (Philadelphia, Pa.)|February 9, 2008
Combining primary and secondary poison prevention in one initiativeEdward Krenzelok, Rita Mrvos, Ellen MazoJournal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|March 14, 2008
Disease surveillance and nonprescription medication sales can predict increases in poison exposureEdward Krenzelok, Erma MacPherson, Rita MrvosJournal of Clinical Pharmacology|July 21, 2006
Hospital pharmacology: An alternative model for practice and training in clinical pharmacologyDavid F Lehmann, Christine M Stork, Roy GuharoyJournal of Pharmacy Practice|July 20, 2011
A national survey on hospital formulary management processesEllena Anagnostis, Cindy Wordell, Roy Guharoy, et al.Pharmacotherapy|October 4, 2003
Vancomycin-induced thrombocytopenia: a case proven with rechallengeJeanna Marraffa, Roy Guharoy, David Duggan, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 21, 2004
West Nile virus infectionRoy Guharoy, Shelley A Gilroy, John A Noviasky, et al.Hospital Pharmacy|June 25, 2014
Bupivacaine liposomal versus bupivacaine: comparative reviewJohn Noviasky, Deirdre P Pierce, Karen Whalen, et al.Chest|February 16, 2013
Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigmRoy Guharoy, John Noviasky, Ziad Haydar, et al.Pageof 3